At close: 12:26:32 PM GMT+11
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-6,977.0000
-6,977.0000
-13,533.0000
-13,162.0000
-14,808.0000
Investing Cash Flow
-89.0000
-89.0000
-610.0000
-836.0000
-246.0000
Financing Cash Flow
-4,747.0000
-4,747.0000
-695.0000
3,228.0000
46,303.0000
End Cash Position
23,360.0000
23,360.0000
35,180.0000
49,918.0000
60,500.0000
Interest Paid Supplemental Data
224.0000
224.0000
277.0000
47.0000
57.0000
Capital Expenditure
-89.0000
-89.0000
-621.0000
-837.0000
-246.0000
Issuance of Capital Stock
--
--
--
--
48,862.0000
Issuance of Debt
886.0000
886.0000
--
4,000.0000
--
Repayment of Debt
-4,888.0000
-4,888.0000
--
--
--
Repurchase of Capital Stock
--
--
--
--
-1,931.0000
Free Cash Flow
-7,066.0000
-7,066.0000
-14,154.0000
-13,999.0000
-15,054.0000
6/30/2021 - 9/26/2000
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TRP.AX Tissue Repair Ltd
0.2550
-1.92%
RNV.AX RENERVE FPO [RNV]
0.1450
-14.71%
VBS.AX Vectus Biosystems Limited
0.0770
0.00%
RCE.AX Recce Pharmaceuticals Ltd
0.4750
-6.86%
ZLD.AX Zelira Therapeutics Limited
0.6000
0.00%
NOX.AX Noxopharm Limited
0.1000
+1.01%
PTX.AX Prescient Therapeutics Limited
0.0410
-2.38%
TYP.AX TRYPTAMINE FPO [TYP]
0.0420
0.00%
PYC.AX PYC Therapeutics Limited
1.5100
-0.66%
RAC.AX Race Oncology Limited
1.3700
-1.44%